Nymox Pharmaceutical Corporation (NYMXF)
OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
Aug 18, 2026, 4:00 PM EST
Nymox Pharmaceutical Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
16
Market Cap
21.01K
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | - | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | 5.00K | -111.00K | -95.69% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| ObsEva | 19.64M |
| Statera Biopharma | 3.69M |
| GeneLink | 1.58M |
| Syros Pharmaceuticals | 386.00K |
| Health Sciences Group | 69.31K |
| NanoLogix | 1.27K |
Nymox Pharmaceutical News
- 2 months ago - Nymox's Nymozarfex(TM) Newly Available for Prostate Treatments for Medical Tourists in Collaboration with the Global Alliance of Regenerative Medicine on Roatan Island in the Caribbean - Accesswire
- 2 months ago - NYMOX Provides Current Update - Accesswire
- 5 months ago - NYMOX Provides Recent Updates - Accesswire
- 1 year ago - Nymox Announces Dismissal of Delaware Action Against Ascella - GlobeNewsWire
- 1 year ago - Nymox resumes trading with listing on OTCQB - TheFly
- 1 year ago - NYMOX Announces Trading Resumed and New Listing on OTCQB Market - GlobeNewsWire
- 2 years ago - Nymox Announces Filing of Annual Report - GlobeNewsWire
- 2 years ago - Nymox Annual Report - GlobeNewsWire